TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34166810

Group type: EXPERIMENTAL
Intervention: Self‐confident model
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Unself‐confident model
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 36176051

Group type: EXPERIMENTAL
Intervention: Single oral dose of 30–720 mg vutiglabridin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 240–480 mg vutiglabridin once daily for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 240 mg single dose of vutiglabridin with a high-fat meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32678452

Group type: EXPERIMENTAL
Intervention: Inhaled vaporized cannabis (4.4% Δ‐9‐tetrahydrocannabinol to 4.9% cannabidiol) 3 times daily for 5 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Inhaled vaporized placebo cannabis 3 times daily for 5 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Inhaled vaporized cannabis
Number of subjects: 27

Group type: COMPARATOR
Intervention: Inhaled vaporized placebo cannabis
Number of subjects: 27
Study: 34473026

Group type: EXPERIMENTAL
Intervention: High BMI
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Preoperative CRP
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Long duration of cardiopulmonary bypass
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Intraoperative anemia
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Postoperative CRP concentration
Number of subjects: 201
Study: 33225642

Group type: EXPERIMENTAL
Intervention: PPV with ERM peeling alone (Group A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: PPV with ERM and ILM peeling (Group B)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 44
Study: 35678800

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg/day orally for 12 weeks)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Telmisartan (20 mg/day orally for 8 weeks)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (carboxy-methyl cellulose once daily)
Number of subjects: 74
Study: 34259398

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 111

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 111

Group type: COMPARATOR
Intervention: Non-acupoint acupuncture
Number of subjects: 111
Study: 32111313

Group type: COMPARATOR
Intervention: Antibiotic group (1 mL/L Enrofloxacin 10% in drinking water for 10 days)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Capsulated immune yolk (12.8 g/kg)
Number of subjects: 480
Study: 33340376

Group type: EXPERIMENTAL
Intervention: Spanish adapted version of the Maslach Burnout Inventory
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 400
Study: 32232261

Group type: EXPERIMENTAL
Intervention: Biscuit mastication with 10% extra-virgin olive oil (EVOB)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Biscuit mastication with 10% palm oil (PALMB)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Biscuit mastication with control biscuit (CONB, 0% lipids)
Number of subjects: 25
Study: 34658020

Group type: EXPERIMENTAL
Intervention: Intraperitoneal ropivacaine (150 mg in 20 mL saline)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 59
Study: 34623242

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 32680561

Group type: EXPERIMENTAL
Intervention: Participant Information Leaflets (PILs) regarding investigational medicinal products
Number of subjects: 0
Study: 35458155

Group type: EXPERIMENTAL
Intervention: Salmon fishmeal
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Whey
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (fasting serum)
Number of subjects: 5
Study: 32649896

Group type: EXPERIMENTAL
Intervention: Flapless piezotome crest split (FPCS)
Number of subjects: 1129

Group type: COMPARATOR
Intervention: Autologous bone block grafting (ABBG)
Number of subjects: 1129
Study: 35301810

Group type: EXPERIMENTAL
Intervention: Rilzabrutinib 100 mg + Ritonavir 100 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Rilzabrutinib 1200 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Rilzabrutinib 400 mg + Ritonavir 100 mg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 51

Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Rilzabrutinib (therapeutic and supratherapeutic concentrations)
Number of subjects: 51
Study: 32450626

Group type: EXPERIMENTAL
Intervention: Mepolizumab (75 mg IV or 100 mg SC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mepolizumab (75 mg IV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35601466

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 500
Study: 32271806

Group type: EXPERIMENTAL
Intervention: Draft genome assembly of Sinapis alba with 96x coverage on the Illumina platform, resulting in a genome size of 459 Mbp covered in 403,423 contigs with an average size of 1138.04 bp.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Development of simple sequence repeat (SSR) markers from the genome assembly, yielding 70731 unique primer pairs.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gene prediction using AUGUSTUS identified 113,107 probable genes with an average size of 684 bp.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GO level annotations recorded after BLASTX results.
Number of subjects: 0
Study: 32333707

Group type: EXPERIMENTAL
Intervention: Public transportation plus active commuting (IG-PT)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Cycling group (IG-C)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Active commuting to work for 12 months
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 73
Study: 34418633

Group type: EXPERIMENTAL
Intervention: Structured diabetes education
Number of subjects: 901

Group type: COMPARATOR
Intervention: Standard diabetes education
Number of subjects: 901
Study: 36158965

Group type: EXPERIMENTAL
Intervention: Traditional Chinese exercise combined with massage (TCEs plus TCM)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Traditional Chinese massage alone (TCM)
Number of subjects: 272
Study: 34643679

Group type: EXPERIMENTAL
Intervention: FACT plus RG (n=80)
Number of subjects: 158

Group type: COMPARATOR
Intervention: FACT as usual (n=78)
Number of subjects: 158
Study: 32702760

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) (≥ 5 minutes)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC) (≤ 20 seconds)
Number of subjects: 73
Study: 33303928

Group type: EXPERIMENTAL
Intervention: Post-HIIE serum (50% autologous serum collected after high intensity interval exercise)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Post-exhaustive exercise serum (50% autologous serum collected after exhaustive exercise)
Number of subjects: 8
Study: 35292212

Group type: EXPERIMENTAL
Intervention: IIS training program (2-hour training including online article, demonstration videos, implementation guide, and informational flyer)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: IIS training program
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (informational flyer only)
Number of subjects: 41
Study: 34907924

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Transcutaneous Electrical Stimulation (TES)
Number of subjects: 70
Study: 33992561

Group type: EXPERIMENTAL
Intervention: Autologous fibrin glue (AFG)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Commercial fibrin glue (CFG)
Number of subjects: 140
Study: 36214590

Group type: EXPERIMENTAL
Intervention: Single screening colonoscopy invitation (invited group)
Number of subjects: 84585

Group type: COMPARATOR
Intervention: No invitation or screening (usual-care group)
Number of subjects: 84585
Study: 33827433

Group type: COMPARATOR
Intervention: Usual care consultations by GPNs
Number of subjects: 53
Study: 34626108

Group type: EXPERIMENTAL
Intervention: Smoking Cessation Program (SCP)
Number of subjects: 48000

Group type: EXPERIMENTAL
Intervention: Smoking Cessation Medication (SCM)
Number of subjects: 48000

Group type: EXPERIMENTAL
Intervention: SCP completion and SCM use
Number of subjects: 48000

Group type: EXPERIMENTAL
Intervention: SCP
Number of subjects: 48000

Group type: EXPERIMENTAL
Intervention: SCM
Number of subjects: 48000
Study: 32225267

Group type: EXPERIMENTAL
Intervention: Mueller matrix images analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fourier spectra of first and fourth row elements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fourier spectra of every MM element
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: M31 element analysis
Number of subjects: 0
Study: 36164138

Group type: COMPARATOR
Intervention: IV Isatuximab (10 mg/kg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: SC Isatuximab (1000 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: SC Isatuximab (1400 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: OBDS Isatuximab (1400 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: SC Isatuximab (1400 mg) + OBDS
Number of subjects: 56
Study: 34689519

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (dietary guidance only)
Number of subjects: 63
Study: 32578755

Group type: EXPERIMENTAL
Intervention: Classes with active participation of students, skills training, and clinical simulation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Classes with active participation of students and skills training
Number of subjects: 34
Study: 35902188

Group type: EXPERIMENTAL
Intervention: Standardised GP‐initiated phone call
Number of subjects: 1834

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1834
Study: 33739218

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 118
Study: 32150514

Group type: EXPERIMENTAL
Intervention: MapMyFitness smartphone application and Facebook-delivered health education intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: Facebook-delivered health education intervention (comparison group)
Number of subjects: 44
Study: 34284167

Group type: EXPERIMENTAL
Intervention: ANT electrical stimulation during working memory task trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ANT electrical stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased gamma power during pre-stimulus and retrieval period
Number of subjects: 0
Study: 35668633

Group type: EXPERIMENTAL
Intervention: High-density lipoprotein (HDL) variability
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Triglyceride variability
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Remnant cholesterol (RC) variability
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) variability
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Variability in other lipids
Number of subjects: 2400
Study: 34645532

Group type: EXPERIMENTAL
Intervention: DA-CPR
Number of subjects: 100

Group type: COMPARATOR
Intervention: U-CPR
Number of subjects: 100
Study: 35275091

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 33187891

Group type: EXPERIMENTAL
Intervention: C0–C2 axial rotation test
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: C0–C2 axial rotation test in subjects with CGH
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: C0–C2 axial rotation test in patients with episodic migraine
Number of subjects: 70
Study: 35644958

Group type: EXPERIMENTAL
Intervention: Medial canthus peribulbar block (PB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 60
Study: 32540634

Group type: EXPERIMENTAL
Intervention: 120 mg of standardized ashwagandha extract (Shoden®) once daily for six weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 35793512

Group type: EXPERIMENTAL
Intervention: Nasal exercises (Group A)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Facial exercises (Group B)
Number of subjects: 56
Study: 33096225

Group type: EXPERIMENTAL
Intervention: Virtual Fitness Buddy Ecosystem (VFB)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no virtual pet)
Number of subjects: 24
Study: 35809401

Group type: EXPERIMENTAL
Intervention: Exclusive human milk diet (human milk formula and human milk derived fortifier)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cow milk-based supplementation (preterm formula and cow milk-based fortifier)
Number of subjects: 38
Study: 33966330

Group type: EXPERIMENTAL
Intervention: Fast blood loss simulation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Slow blood loss simulation
Number of subjects: 21
Study: 34762533

Group type: EXPERIMENTAL
Intervention: PBM before & after pain stimulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PBM before pain stimulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PBM after pain stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34217572

Group type: COMPARATOR
Intervention: Standard dose-interval (2 weeks)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Extended dose-interval (6 months)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Both dose-intervals
Number of subjects: 156
Study: 33636416

Group type: EXPERIMENTAL
Intervention: Baseline plasma ET-1 levels
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Change in ET-1 levels over 24 weeks
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Baseline ET-1 levels
Number of subjects: 210
Study: 34579149

Group type: EXPERIMENTAL
Intervention: Dietary intervention including dietary assessment, individual feedback, and dietary guidance
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 194
Study: 36198461

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (TT) + Long pulse width stimulation (LPWS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Testosterone treatment (TT) + neuromuscular electrical stimulation via telehealth
Number of subjects: 24
Study: 34591518

Group type: EXPERIMENTAL
Intervention: Positive message about individuals who use PBS
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Negative message about individuals who do not use PBS
Number of subjects: 147

Group type: COMPARATOR
Intervention: Assessment‐only control group
Number of subjects: 147
Study: 35217515

Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy with 24 Gray epimacular brachytherapy (EMB) and pro re nata (PRN) ranibizumab, n=224
Number of subjects: 363

Group type: COMPARATOR
Intervention: PRN ranibizumab monotherapy, n=119
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: EMB group
Number of subjects: 363

Group type: COMPARATOR
Intervention: Ranibizumab group
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: EMB group (participants with microvascular abnormalities at month 24)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: EMB group (participants without microvascular abnormalities at month 24)
Number of subjects: 363
Study: 32565105

Group type: EXPERIMENTAL
Intervention: Dart-throwing motion (DTM) plane exercise
Number of subjects: 24
Study: 32701508

Group type: EXPERIMENTAL
Intervention: Tesamorelin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35037813

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 485
Study: 33449396

Group type: EXPERIMENTAL
Intervention: Sterile water (0.2 mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hypertonic saline (58.5 mg/mL; active control)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isotonic saline (0.9 mg/mL; passive control)
Number of subjects: 30

Group type: COMPARATOR
Intervention: All substances
Number of subjects: 30
Study: 32080074

Group type: EXPERIMENTAL
Intervention: Phellinus linteus (PL) 1,000 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phellinus linteus (PL) 1,500 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 35796831

Group type: EXPERIMENTAL
Intervention: Modified mindfulness-based stress reduction (MBSR) program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 33653745

Group type: EXPERIMENTAL
Intervention: Preschool HABIT-ILE
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 35809255

Group type: EXPERIMENTAL
Intervention: O‐R electric rechargeable toothbrush (Oral‐B iO with Oral‐B Gentle Care brush head)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Soft manual toothbrush (Oral‐B Indicator)
Number of subjects: 100
Study: 33998155

Group type: COMPARATOR
Intervention: Introducer needle (Group “I”)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Spring‐loaded pneumoperitoneum (Veress) needle (Group “V”)
Number of subjects: 426
Study: 33413217

Group type: EXPERIMENTAL
Intervention: High genetic risk group
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Low genetic risk group
Number of subjects: 1600
Study: 32034403

Group type: EXPERIMENTAL
Intervention: New Nordic Diet (NND) high in dietary fiber, whole grain, intrinsic sugars, and starch for 26 weeks
Number of subjects: 62
Study: 35022317

Group type: EXPERIMENTAL
Intervention: High-caloric fatty supplement (HCFS; 405 kcal/day, 100% fat)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ultra-high-caloric fatty supplement (UHCFS; 810 kcal/day, 100% fat)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ultra-high-caloric, carbohydrate-rich supplement (UHCCS; 900 kcal/day, 49% carbohydrates)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open control (OC) group without any supplement
Number of subjects: 64
Study: 33199226

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine perfusion
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline perfusion (Control)
Number of subjects: 24
Study: 33048923

Group type: EXPERIMENTAL
Intervention: SMASH intervention (pharmacist-led Safety Medication dASHboard)
Number of subjects: 47413
Study: 32997348

Group type: EXPERIMENTAL
Intervention: Pain-specific mindful attention training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonspecific mindful attention training
Number of subjects: 60

Group type: COMPARATOR
Intervention: No mindful attention training
Number of subjects: 60
Study: 35246099

Group type: EXPERIMENTAL
Intervention: Live your life without diabetes intervention
Number of subjects: 127

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 127
Study: 33407710

Group type: EXPERIMENTAL
Intervention: Intervention A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intervention B
Number of subjects: 0
Study: 34311747

Group type: EXPERIMENTAL
Intervention: Biomechanical intervention group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention group (both biomechanical and psychosocial intervention)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 33228496

Group type: EXPERIMENTAL
Intervention: Spiritual care
Number of subjects: 80
Study: 35973788

Group type: EXPERIMENTAL
Intervention: Support from dermatological nurses
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard care without nurse support
Number of subjects: 103
Study: 33523933

Group type: EXPERIMENTAL
Intervention: Political leaders in nondemocracies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chief executive officers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sports coaches
Number of subjects: 0
Study: 33327282

Group type: EXPERIMENTAL
Intervention: Family nursing with the assistance of network (FNAN)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine family nursing care (Control Group)
Number of subjects: 112
Study: 35412099

Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (RCA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Heparin-free protocol
Number of subjects: 41
Study: 34016302

Group type: EXPERIMENTAL
Intervention: VR PRE after 15-second VR smoking memory retrieval (G1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard extinction procedure after retrieval (G3)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No exposure to smoking memory retrieval (G2)
Number of subjects: 46
Study: 32507535

Group type: EXPERIMENTAL
Intervention: Inhalation of 6 drops of 40% damask rose essential oil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (6 drops of distilled water)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 34410498

Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide (White Class 10%, FGM) applied once daily for 60 min to the buccal surface for 14 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: 10% hydrogen peroxide (White Class 10%, FGM) applied once daily for 60 min to the lingual surface for 14 days
Number of subjects: 25
Study: 34551492

Group type: EXPERIMENTAL
Intervention: PSI-TKA (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: CI-TKA (n=40)
Number of subjects: 80
Study: 32757302

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pembrolizumab plus acalabrutinib
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 75

Group type: COMPARATOR
Intervention: Acalabrutinib plus pembrolizumab
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 75
Study: 36102400

Group type: EXPERIMENTAL
Intervention: Mixed method (specially developed for this study)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Parent-Led Weaning (PLW)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Baby-Led Introduction to SolidS (BLISS)
Number of subjects: 139

Group type: COMPARATOR
Intervention: PLW and BLISS methods (non-adherence)
Number of subjects: 139